A Phase IIa Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Escalation Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation.
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2013
At a glance
- Drugs Plecanatide (Primary)
- Indications Constipation
- Focus Adverse reactions
- 09 May 2013 Detailed positive findings will be presented at the 2013 Digestive Disease Week (DDW) and will be published in 2013, according to a Synergy Pharmaceuticals Inc media release.
- 05 Nov 2010 According to a Synergy Pharmaceuticals media release the trial status changed from recruiting to completed.
- 07 Oct 2010 Results will be presented at the American College of Gastroenterology Annual Scientific meeting (Poster Number P762), according to a Synergy Pharmaceuticals media release.